rdf:type |
|
lifeskim:mentions |
umls-concept:C0006142,
umls-concept:C0008976,
umls-concept:C0085533,
umls-concept:C0242793,
umls-concept:C0246415,
umls-concept:C0332293,
umls-concept:C0549177,
umls-concept:C0596545,
umls-concept:C0746319,
umls-concept:C1280500,
umls-concept:C1305855,
umls-concept:C1516213
|
pubmed:issue |
1
|
pubmed:dateCreated |
2009-12-10
|
pubmed:abstractText |
Obesity has been shown to be an indicator of poor prognosis for patients with primary breast cancer (BC) regardless of the use of adjuvant systemic therapy.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1573-7217
|
pubmed:author |
pubmed-author:AnderssonMichaelM,
pubmed-author:CrownJohn P AJP,
pubmed-author:DemolJanJ,
pubmed-author:DewarJoannaJ,
pubmed-author:Di LeoAngeloA,
pubmed-author:FrancisPrudenceP,
pubmed-author:GelberRichard DRD,
pubmed-author:GiulianiRosaR,
pubmed-author:GutiérezJorgeJ,
pubmed-author:JakeszRaimundR,
pubmed-author:LluchAnaA,
pubmed-author:McCaskill-StevensWortaW,
pubmed-author:NordenskjöldBoB,
pubmed-author:OlsenStevenS,
pubmed-author:Piccart-GebhartMartineM,
pubmed-author:QuinauxEmmanuelE,
pubmed-author:SantoroArmandoA,
pubmed-author:VicenteMalouM,
pubmed-author:VilaMireia MargeliMM,
pubmed-author:de AzambujaEvandroE
|
pubmed:issnType |
Electronic
|
pubmed:volume |
119
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
145-53
|
pubmed:meshHeading |
pubmed-meshheading:19731015-Adult,
pubmed-meshheading:19731015-Aged,
pubmed-meshheading:19731015-Antineoplastic Agents,
pubmed-meshheading:19731015-Body Mass Index,
pubmed-meshheading:19731015-Breast Neoplasms,
pubmed-meshheading:19731015-Chemotherapy, Adjuvant,
pubmed-meshheading:19731015-Disease-Free Survival,
pubmed-meshheading:19731015-Doxorubicin,
pubmed-meshheading:19731015-Female,
pubmed-meshheading:19731015-Humans,
pubmed-meshheading:19731015-Lymphatic Metastasis,
pubmed-meshheading:19731015-Middle Aged,
pubmed-meshheading:19731015-Obesity,
pubmed-meshheading:19731015-Prognosis,
pubmed-meshheading:19731015-Retrospective Studies,
pubmed-meshheading:19731015-Taxoids,
pubmed-meshheading:19731015-Treatment Outcome
|
pubmed:year |
2010
|
pubmed:articleTitle |
The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial.
|
pubmed:affiliation |
Institut Jules Bordet and Université Libre de Bruxelles (U.L.B), Brussels, Belgium.
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase III
|